Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spermidine/spermine N1-acetyltransferase 1 (SAT1), also known as diamine acetyltransferase 1 or SSAT, is a key enzyme in polyamine metabolism. It catalyzes the N(1)-acetylation of spermidine and spermine, which are essential polyamines involved in cell growth, chromatin structure maintenance, and other cellular functions. SAT1 acts as a rate-limiting enzyme in the catabolic pathway of polyamine metabolism. Alterations in SAT1 activity have been linked to cell growth, cancer, and metabolism. It serves as both a biomarker candidate for disease states like cancer and a potential therapeutic target.
Acetylation of spermidine and spermine
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spermidine/spermine N1-acetyltransferase 1 (SSAT).